Back to Search
Start Over
[Atomoxetine for treatment of children and adolescents with ADHD].
- Source :
-
Ugeskrift for laeger [Ugeskr Laeger] 2014 Mar 03; Vol. 176 (10A). - Publication Year :
- 2014
-
Abstract
- Atomoxetine reduces ADHD symptoms in children and adolescents significantly and is indicated for ADHD with co-morbid anxiety, depression and tics or with an increased risk of abuse. Number needed to treat is 3.4-5. Common adverse effects are stomach pain, decreased appetite and somnolence. Serious adverse effects include increased vascular tone, decreased growth rate and increased suicidal behaviour. In most cases adverse effects are mild to moderate and transient. Since atomoxetine was launched in 2006, 117 cases of toxic exposures have been reported in Denmark.
- Subjects :
- Adolescent
Adrenergic Uptake Inhibitors adverse effects
Adrenergic Uptake Inhibitors pharmacology
Atomoxetine Hydrochloride adverse effects
Atomoxetine Hydrochloride pharmacology
Child
Humans
Adrenergic Uptake Inhibitors therapeutic use
Atomoxetine Hydrochloride therapeutic use
Attention Deficit Disorder with Hyperactivity drug therapy
Subjects
Details
- Language :
- Danish
- ISSN :
- 1603-6824
- Volume :
- 176
- Issue :
- 10A
- Database :
- MEDLINE
- Journal :
- Ugeskrift for laeger
- Publication Type :
- Academic Journal
- Accession number :
- 25350704